Announce Date | 04/23/2025 |
EPS Normalized Actual | $1.28 (Beat by $0.21) |
EPS GAAP Actual | $1.28 (Beat by $0.21) |
Revenue Actual | $4.069B |
Revenue Surprise | Beat by $4069M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.53255 |
EPS GAAP Estimate | $1.53255 |
Revenue Estimate | $4.417461856B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 0 | INF | 0 | 0 | 2 |
Dec 2028 | 11.78 | 18.34 | 10.32308 | 13.95997 | 5 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.29 | 1.29 | 4.069B | 10.03% | 4069M |
FQ4 2024 (Dec 2024) | 1.32 | 1.32 | 4.007B | -1.75% | 4007M |
FQ3 2024 (Sep 2024) | 1.49 | 1.49 | 4.151B | -9.18% | 4151M |
FQ2 2024 (Jun 2024) | 1.23 | 1.23 | 3.822B | -18.55% | 3822M |
FQ1 2024 (Mar 2024) | 1.21 | 1.21 | 3.661B | -19.61% | 3661M |
FQ4 2023 (Dec 2023) | 1.51 | 1.51 | 4.077B | -14.55% | 4077M |
FQ3 2023 (Sep 2023) | 1.88 | 1.88 | 4.532B | -15.64% | 4532M |
FQ2 2023 (Jun 2023) | 1.9 | 1.9 | 4.531B | -15.03% | 4531M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
1.53255
Consensus Revenue Estimates
4.417461856B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.17 | -- | 2.11902 | 2.31118 | 12 |
FQ3 2027 (Sep 2027) | 2.09 | -- | 2.0409 | 2.22598 | 7 |
FQ2 2027 (Jun 2027) | 1.91 | -- | 1.86513 | 2.03427 | 7 |
FQ1 2027 (Mar 2027) | 1.78 | -- | 1.73818 | 1.89581 | 8 |
FQ4 2026 (Oct 2026) | 2.19137 | -- | 2.0554 | 2.37954 | 7 |
FQ3 2026 (Jul 2026) | 2.03683 | -- | 1.91045 | 2.21173 | 12 |
FQ2 2026 (Jun 2026) | 2.00005 | -- | 1.9202 | 2.19298 | 7 |
FQ1 2026 (Mar 2026) | 1.8721 | 31.09 | 1.79736 | 2.05269 | 9 |
FQ4 2025 (Oct 2025) | 1.70309 | 22.49 | 1.59741 | 1.84934 | 8 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 5.24B | -- | 5.15B | 5.51B | 7 |
FQ3 2027 (Sep 2027) | 5.34B | -- | 5.25B | 5.61B | 7 |
FQ2 2027 (Jun 2027) | 5.13B | -- | 5.04B | 5.39B | 7 |
FQ1 2027 (Mar 2027) | 4.92B | -- | 4.83B | 5.17B | 7 |
FQ4 2026 (Oct 2026) | 5.65B | -- | 5.38B | 6.03B | 8 |
FQ3 2026 (Jul 2026) | 5.39B | -- | 5.13B | 5.74B | 13 |
FQ2 2026 (Jun 2026) | 5.33B | -- | 5.16B | 5.72B | 8 |
FQ1 2026 (Mar 2026) | 5.07B | 19.79 | 4.92B | 5.45B | 10 |
FQ4 2025 (Oct 2025) | 4.67B | 14.23 | 4.45B | 4.98B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.29 | 1.29 | 100% | |
FQ4 2024 (Dec 2024) | 1.32 | 1.32 | 100% | |
FQ3 2024 (Sep 2024) | 1.49 | 1.49 | 100% | |
FQ2 2024 (Jun 2024) | 1.23 | 1.23 | 100% | |
FQ1 2024 (Mar 2024) | 1.21 | 1.21 | 100% | |
FQ4 2023 (Dec 2023) | 1.51 | 1.51 | 100% | |
FQ3 2023 (Sep 2023) | 1.88 | 1.88 | 100% | |
FQ2 2023 (Jun 2023) | 1.9 | 1.9 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $4.07B | $4069M | 100% |
FQ4 2024 (Dec 2024) | $0B | $4.01B | $4007M | 100% |
FQ3 2024 (Sep 2024) | $0B | $4.15B | $4151M | 100% |
FQ2 2024 (Jun 2024) | $0B | $3.82B | $3822M | 100% |
FQ1 2024 (Mar 2024) | $0B | $3.66B | $3661M | 100% |
FQ4 2023 (Dec 2023) | $0B | $4.08B | $4077M | 100% |
FQ3 2023 (Sep 2023) | $0B | $4.53B | $4532M | 100% |
FQ2 2023 (Jun 2023) | $0B | $4.53B | $4531M | 100% |